VGI Health Technology Limited (NSX:VTL) Update on Sale of Invictus BioPharma

On 5 April 2022, the Directors of VGI Health Technology Limited (NSX:VTL) announced the sale of its wholly owned subsidiary, Invictus BioPharma Pty Ltd to Invictus BioPharma Holdings Ltd (IVBHL) (the Transaction).

Related Keywords

Australia ,Sydney ,New South Wales ,Australian ,Invictus Biopharma ,Health Technology Limited ,Health Technology ,Technology Limited ,Invictus Biopharma Pty Ltd ,Invictus Biopharma Holdings Ltd ,Sunset Date ,Delayed Onset Muscle Soreness ,Non Alcoholic Fatty Liver Disease ,Non Alcoholic Steatohepatitis ,Print This ,Page Viewed ,Biotech ,Clinical Trials ,Drugs Otc ,Vgi Health Technology Limited ,Nsx Vtl ,